Epidemiologic Features of the Monkeypox Outbreak and the Public Health Response — United States, May 17–October 6, 2022
| Autor: | Christine Marie Kava, Dallas M. Rohraff, Bailey Wallace, Jennifer L. Mendoza-Alonzo, Dustin W. Currie, Anna E. Munsey, Nicole M. Roth, Jonathan Bryant-Genevier, Jordan L. Kennedy, Daniel L. Weller, Athalia Christie, Jennifer H. McQuiston, Peter Hicks, Penelope Strid, Emily Sims, Maria E. Negron, Kashif Iqbal, Sascha Ellington, Dawn K. Smith |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
Adult
Male Health (social science) Epidemiology Health Toxicology and Mutagenesis Gender Identity HIV Infections Monkeypox General Medicine United States Disease Outbreaks Sexual and Gender Minorities Health Information Management Cause of Death Ethnicity Humans Female Homosexuality Male Minority Groups |
| Zdroj: | MMWR. Morbidity and Mortality Weekly Report. 71:1449-1456 |
| ISSN: | 1545-861X 0149-2195 |
| DOI: | 10.15585/mmwr.mm7145a4 |
| Popis: | On May 17, 2022, the Massachusetts Department of Health announced the first suspected case of monkeypox associated with the global outbreak in a U.S. resident. On May 23, 2022, CDC launched an emergency response (1,2). CDC's emergency response focused on surveillance, laboratory testing, medical countermeasures, and education. Medical countermeasures included rollout of a national JYNNEOS vaccination strategy, Food and Drug Administration (FDA) issuance of an emergency use authorization to allow for intradermal administration of JYNNEOS, and use of tecovirimat for patients with, or at risk for, severe monkeypox. During May 17-October 6, 2022, a total of 26,384 probable and confirmed* U.S. monkeypox cases were reported to CDC. Daily case counts peaked during mid-to-late August. Among 25,001 of 25,569 (98%) cases in adults with information on gender identity |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|